Article
Design of human granzyme B variants resistant to serpin B9.
Proteins - 1 Nov 2012
Losasso Valeria, Schiffer Sonja, Barth Stefan, Carloni Paolo
Abstract excerpt
Human granzyme B (hGB) is a serine protease involved in immune-mediated apoptosis. Its cytotoxicity makes it potentially applicable in cancer therapy. However, the effectiveness of hGB can be hampered by the cytosolic expression of a natural protein inhibitor, human Serpin B9 (hSB9). Here, we used computational approaches to identify hGB mutations that can affect its binding to hSB9 without significantly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
